Outsourcing clinical trial activities to specialist data-focused CROs is growing rapidly, driven by the need for expert data management, biostatistics, and faster time to market. These partnerships deliver cleaner, more reliable data, streamlined operations, and faster regulatory acceptance.
In an article for International Clinical Trials, Stephen Corson, Associate Director, Statistics & Technical Solutions at Phastar explains how by choosing the right specialist CRO, sponsors can accelerate development, reduce costs, and bring therapies to patients more efficiently.
”Unlike full-service CROs, specialist companies are more likely to retain expert staff because of their own reputation within the field and focus on investment. This ensures all clients can access top talent and helps to increase efficiency as team disruptions are limited.”